Results 91 to 100 of about 732,366 (171)
The emergence of percutaneous treatment options provides novel therapeutic alternatives for older and feeble patients who are at high risk for any surgical procedure.
Nikolaos Ktenopoulos +8 more
doaj +1 more source
A 49-year-old woman with a congenital quadricuspid aortic valve presented in cardiogenic shock due to severe aortic regurgitation. She underwent transfemoral transcatheter aortic valve replacement with a 29 mm self-expanding prosthesis. The procedure was
Abdullah Aljudaibi +2 more
doaj +1 more source
Mid-Term Outcomes and Echocardiographic Predictors of TTVR: Insights from the TRAVEL Study
Background: The mid-term prognosis after transcatheter tricuspid valve replacement (TTVR) is poorly defined, and echocardiographic predictors remain uncertain.
Xing Zhao +8 more
doaj +1 more source
Managing Bradycardia in Patients After Transcatheter Tricuspid Valve Replacement
The recent development and approval of a transcatheter tricuspid valve represent a significant breakthrough in the management of patients with tricuspid regurgitation who are not suitable for existing invasive or interventional therapies.
Andreas Hain, MD +6 more
doaj +1 more source
Case report of a transcatheter tricuspid valve-in-valve replacement
Transcatheter valve implantations in the tricuspid position are infrequent. We report a case of an Edwards SAPIEN 3 (S3) implantation in the tricuspid position as a transcatheter valve-in-valve procedure in a 12-year-old patient deemed at high risk for ...
Pillay, DN, Brown, SC, Buys, DG
core +1 more source
Hanna A Jensen, Lillian L Tsai, Vinod H Thourani Division of Cardiothoracic Surgery, Joseph B Whitehead Department of Surgery, Structural Heart and Valve Center, Emory University School of Medicine, Atlanta, GA, USA Abstract: Severe aortic stenosis (AS)
Tsai LL, Jensen HA, Thourani VH
core
Antithrombotic Treatment After Transcatheter Valve Interventions: Current Status and Future Directions. [PDF]
PURPOSE The optimal antithrombotic strategy after transcatheter valve interventions is a subject of ongoing debate. Although there is evidence from randomized trials in patients undergoing transcatheter aortic valve replacement (TAVR), current ...
Maznyczka, Annette, Pilgrim, Thomas
core +2 more sources
Clinical Characteristics and Outcomes of Patients Screened for Transcatheter Tricuspid Valve Replacement: The TriACT Registry. [PDF]
BACKGROUND Transcatheter tricuspid valve replacement (TTVR) abolishes tricuspid regurgitation (TR) and has emerged as a definitive treatment for TR.
Latib, Azeem +19 more
core +1 more source
Choosing Between Tricuspid Repair or Replacement: Decision Algorithms
Transcatheter tricuspid valve (TV) interventions have transformed the treatment of TV disease. Among available therapies, transcatheter tricuspid edge-to-edge repair has shown favorable safety, symptom relief, quality-of-life improvement, and reduction ...
Hannah Kempton, MD +8 more
doaj +1 more source
Clinical Outcomes Following Transcatheter Tricuspid Valve Replacement – A Meta-Analysis
Background: Tricuspid regurgitation (TR) is associated with substantial morbidity and mortality, yet it remains an undertreated entity. Transcatheter tricuspid valve replacement (TTVR) has emerged as a promising therapeutic option, with multiple novel ...
Taha Hatab, MD +11 more
doaj +1 more source

